Definitive three-dimensional high-dose-rate brachytherapy for inoperable endometrial cancer.

J Contemp Brachytherapy · 2017 · PMC5437086 · PMID 28533799

Europe PMC DOI

hedged sentence

0.0600

closest p · 1.2× alpha

0.0600

boldest claim

The sentences

did not reach statistical significancep = 0.06so close (0.05 < p ≤ 0.1)

Also the stage seemed to influence LC at 1 year: 50% for stage III, and 91% for stage I, but this difference did not reach statistical significance ( p = 0.06).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.